BBC reports on findings from a clinical trial testing an “immune reset” approach for lupus, with some participants achieving remission without needing ongoing medication to control their condition. The report highlights patient experience, describing individuals who say they have “never been this good,” reflecting improvement in symptoms and disease management during the trial period. According to the BBC summary, patients in the trial have not required medication to manage lupus while on the study treatment. The article frames the results as notable given lupus is typically a chronic condition that often requires long-term therapies to prevent flares. The report characterizes the approach as potentially “revolutionary,” but it also presents the information in the context of a trial, indicating the findings are still part of clinical research rather than established standard care. Overall, the reporting focuses on remission and reduced need for medication among trial participants, while keeping the emphasis on early evidence from a study setting.